Although many HNSCC are EGFR-positive, PET with [64Cu]Cu-labeled mAbs would confirm lesions as EGFR-positive and importantly predict the tumour and normal tissue uptake of [177Lu]Lu-labeled anti-EGFR mAbs. Here, EGFR is linked to neoplasm.